STERIS plc

NYQ: STE
Live Quote

📈 ZcoreAI Score

Our AI model analyzes STERIS plc's price action across multiple timeframes using regression channels and statistical scoring.

Get STE Z-Score →

About STERIS plc

Healthcare Medical Devices
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

📊 Fundamental Analysis

STERIS plc demonstrates a healthy profit margin of 12.1%.

The company recently reported 9.2% revenue growth, which is above average for the Healthcare sector.

Return on Equity (ROE) is 10.5%, which suggests room for improvement in capital utilization.

At a current price of $222.58, STE currently sits at the 21st percentile of its 52-week range (Range: $209.98 - $269.44).

💰 Valuation Insight

STE is valued broadly in line with the sector at a PE of 31.04. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

⚠️ Profit Margin Moderate
Debt/Equity Excellent
⚠️ Revenue Growth Moderate
🔴 Return on Equity Weak
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$21.85B
Trailing P/E
31.04
Forward P/E
20.09
Beta (5Y)
1.07
52W High
$269.44
52W Low
$209.98
Avg Volume
844K
Day High
Day Low
Get STE Z-Score on Dashboard 🚀